Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
PTPRB,Receptor-type tyrosine-protein phosphatase beta,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,69,1.05 [1.02-1.08],0.000407386501069725,trans
PTPRB,Receptor-type tyrosine-protein phosphatase beta,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Wald ratio,1,0.92 [0.85-0.99],0.0339646508763845,trans
PTPRB,Receptor-type tyrosine-protein phosphatase beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Inverse variance weighted,3,1.04 [1-1.08],0.0670991417756429,trans
PTPRB,Receptor-type tyrosine-protein phosphatase beta,Chapter IX Diseases of the circulatory system,I9_PAD,Inverse variance weighted,2,1.04 [0.9-1.19],0.626602581831768,trans
PTPRB,Receptor-type tyrosine-protein phosphatase beta,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,3,0.98 [0.91-1.07],0.699792103710837,trans
PTPRB,Receptor-type tyrosine-protein phosphatase beta,Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,11,1.01 [0.95-1.07],0.783527210051308,trans
PTPRB,Receptor-type tyrosine-protein phosphatase beta,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,2,1.02 [0.88-1.17],0.811759803828691,trans
PTPRB,Receptor-type tyrosine-protein phosphatase beta,Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Wald ratio,1,0.99 [0.92-1.08],0.880484484948924,trans
